Despite the rarity of such variants in DYSF, their evaluation should be included in cases where dysferlinopathy is highly expected and only one P/LP DYSF variant has been identified. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.